Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea · Delayed Price · Currency is KRW 1,635.00
+100.00 (6.51%)
At close: Aug 24, 2026
Kyung Nam Pharm Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 44,411 | 50,814 | 25,960 | 42,992 | 22,931 | 22,728 |
Short-Term Investments | - | - | 0 | 500 | 0 | - |
Trading Asset Securities | - | - | 9,053 | 1,985 | 316.23 | 4,766 |
Cash & Short-Term Investments | 44,411 | 50,814 | 35,013 | 45,478 | 23,248 | 27,495 |
Cash Growth | 31.85% | 45.13% | -23.01% | 95.62% | -15.45% | 14.86% |
Accounts Receivable | 13,616 | 14,124 | 18,321 | 13,753 | 16,063 | 19,536 |
Other Receivables | 436.21 | 62.98 | 602.48 | 116.91 | 337.14 | 82.16 |
Receivables | 14,052 | 14,187 | 19,314 | 13,870 | 16,451 | 19,670 |
Inventory | 13,197 | 12,215 | 13,478 | 12,611 | 13,979 | 9,664 |
Prepaid Expenses | 73.22 | 125.14 | 508.29 | 1,050 | 976.54 | 157 |
Other Current Assets | 316.92 | 484.01 | 985.2 | 1,729 | 265.91 | 653.05 |
Total Current Assets | 72,050 | 77,825 | 69,298 | 74,738 | 54,920 | 57,639 |
Property, Plant & Equipment | 32,723 | 32,327 | 46,710 | 31,235 | 33,852 | 32,227 |
Long-Term Investments | 14,674 | 16,560 | 5,426 | - | - | - |
Goodwill | - | - | 4,190 | - | 139.69 | 139.69 |
Other Intangible Assets | 335.36 | 368.38 | 5,454 | 804.76 | 924.01 | 620.12 |
Long-Term Accounts Receivable | -0 | -0 | 0 | -0 | -0 | 0 |
Long-Term Deferred Tax Assets | 118.31 | 135.03 | 881.21 | 1,922 | 7,530 | 7,678 |
Other Long-Term Assets | 40,318 | 39,369 | 34,650 | 29,568 | 27,940 | 28,352 |
Total Assets | 160,219 | 166,584 | 166,609 | 138,269 | 125,307 | 126,655 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 4,322 | 5,557 | 7,242 | 3,366 | 4,430 | 6,341 |
Accrued Expenses | 707.07 | 755.58 | 1,134 | 532.96 | 566.29 | 805.93 |
Short-Term Debt | 7,065 | 9,396 | 17,497 | 8,776 | 11,415 | 11,618 |
Current Portion of Long-Term Debt | 24,000 | 24,000 | 24,185 | 24,000 | 1,800 | 1,800 |
Current Portion of Leases | 203.68 | 115.62 | 563.48 | 220.1 | 342.5 | 296.41 |
Current Income Taxes Payable | - | 1.69 | 56.76 | 0.86 | 0.77 | - |
Current Unearned Revenue | - | - | 215.02 | - | - | - |
Other Current Liabilities | 4,614 | 6,453 | 16,039 | 7,051 | 6,857 | 17,744 |
Total Current Liabilities | 40,911 | 46,279 | 66,933 | 43,947 | 25,411 | 38,605 |
Long-Term Debt | 4,000 | 4,000 | 8,760 | - | 25,650 | 27,450 |
Long-Term Leases | 438.52 | 74.87 | 324.71 | 197.08 | 308.13 | 228.1 |
Pension & Post-Retirement Benefits | 1,374 | 633.78 | - | - | 816.02 | 2,172 |
Other Long-Term Liabilities | 6 | 373.11 | 759.43 | 354.33 | 592.33 | 836.36 |
Total Liabilities | 46,729 | 51,361 | 76,777 | 44,498 | 52,778 | 69,291 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 7,815 | 7,815 | 17,797 | 16,740 | 10,025 | 8,721 |
Additional Paid-In Capital | 127,603 | 141,835 | 104,275 | 98,061 | 72,237 | 56,009 |
Retained Earnings | -24,081 | -36,570 | -45,041 | -23,102 | -11,506 | -9,173 |
Treasury Stock | -1.08 | -1.08 | -1.08 | -1.08 | -1.08 | -1.08 |
Comprehensive Income & Other | 2,155 | 2,144 | 2,332 | 2,074 | 1,774 | 1,807 |
Total Common Equity | 113,490 | 115,223 | 79,362 | 93,771 | 72,529 | 57,364 |
Minority Interest | - | - | 10,471 | - | - | - |
Shareholders' Equity | 113,490 | 115,223 | 89,832 | 93,771 | 72,529 | 57,364 |
Total Liabilities & Equity | 160,219 | 166,584 | 166,609 | 138,269 | 125,307 | 126,655 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 35,707 | 37,587 | 51,330 | 33,193 | 39,515 | 41,392 |
Net Cash (Debt) | 8,705 | 13,228 | -16,318 | 12,285 | -16,268 | -13,898 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 340.25 | 1521.69 | -2301.43 | 2105.17 | -3560.18 | -4028.82 |
Filing Date Shares Outstanding | 15.63 | 15.63 | 7.12 | 6.7 | 4.01 | 3.49 |
Total Common Shares Outstanding | 15.63 | 15.63 | 7.12 | 6.7 | 4.01 | 3.49 |
Working Capital | 31,139 | 31,546 | 2,365 | 30,792 | 29,509 | 19,035 |
Book Value Per Share | 7261.33 | 7372.20 | 11148.44 | 14004.22 | 18087.67 | 16443.90 |
Tangible Book Value | 113,155 | 114,855 | 69,717 | 92,966 | 71,465 | 56,604 |
Tangible Book Value Per Share | 7239.87 | 7348.63 | 9793.63 | 13884.03 | 17822.40 | 16226.09 |
Land | - | 20,049 | 27,988 | 17,715 | 15,707 | 15,707 |
Buildings | - | 11,337 | 13,013 | 10,979 | 9,860 | 9,754 |
Machinery | - | 10,049 | 13,168 | 10,648 | 10,553 | 7,733 |
Construction In Progress | - | 184.45 | 888.2 | 164.4 | 4,974 | 6,379 |